Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE1 | P24864 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.36 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25000856 | 0.77 | POLB (0.39) | KDM4EALDH1A1 | |
| SCHEMBL932978 | 0.71 | — | — | |
| SCHEMBL24166743 | 0.71 | CCNE1 (0.37) | CCNE1CDK2CDK5FFAR2KDM4E | |
| SCHEMBL28986430 | 0.71 | CCNE1 (0.37) | CCNE1CDK2CDK5FFAR2KDM4E | |
| SCHEMBL30276270 | 0.71 | CCNE1 (0.37) | CCNE1CDK2CDK5FFAR2KDM4E | |
| SCHEMBL28477655 | 0.71 | CYP2A6 (0.36) | KDM4EALDH1A1CYP2A6 | |
| SCHEMBL6455262 | 0.71 | CCNE1 (0.36) | CCNE1CDK2CDK5FFAR2 | |
| SCHEMBL16114009 | 0.67 | — | — | |
| SCHEMBL10272882 | 0.67 | — | — | |
| SCHEMBL2901458 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368636-A1 | NOVEL HETEROCYCLIC COMPOUND, SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION | THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) | 2025-12-04 | — | — | US | disclosed |
| WO-2023238683-A1 | NOVEL HETEROCYCLIC COMPOUND AND SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION | 国立大学法人電気通信大学 | 2023-12-14 | — | — | WO | disclosed |
| US-11807612-B2 | Heterocyclic compound and salt thereof, and luminescent substrate composition | THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11807612-B2 | Heterocyclic compound and salt thereof, and luminescent substrate composition | THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11807612-B2 | Heterocyclic compound and salt thereof, and luminescent substrate composition | THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) | 2023-11-07 | — | — | US | disclosed |
| US-20230192635-A1 | NOVEL HETEROCYCLIC COMPOUND AND SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION | THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) | 2023-06-22 | — | — | US | disclosed |
| US-20230192635-A1 | NOVEL HETEROCYCLIC COMPOUND AND SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION | THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) | 2023-06-22 | — | — | US | disclosed |
| US-20230192635-A1 | NOVEL HETEROCYCLIC COMPOUND AND SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION | THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) | 2023-06-22 | — | — | US | disclosed |
| CN-115996914-A | Novel heterocyclic compound and salt thereof, and luminescent substrate composition | 国立大学法人电气通信大学 | 2023-04-21 | — | — | CN | disclosed |
| WO-2022004744-A1 | NOVEL HETEROCYCLIC COMPOUND AND SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION | 国立大学法人電気通信大学 | 2022-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11807612-B2 | Heterocyclic compound and salt thereof, and luminescent substrate composition | RXFP4, NR2E3, ARRB1 | CCNE1 1781/4885CDK2 2984/4885CDK5 4463/4885 |
| US-20230192635-A1 | NOVEL HETEROCYCLIC COMPOUND AND SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION | RXFP4, CRY1, NOX4 | CCNE1 1588/4885CDK2 2611/4885CDK5 4355/4885 |
| US-20250368636-A1 | NOVEL HETEROCYCLIC COMPOUND, SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION | OXSR1, RER1, NR2E3 | CCNE1 1244/4885CDK2 2571/4885CDK5 2479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.